Pakistan's drug regulator approved phase 3 trials of another Chinese COVID-19 vaccine on Monday, according to local media.
The trials of the ZF2001 vaccine, developed by the Chinese Academy of Sciences with a unit of Chongqing Zhifei Biological Products, will begin next week.
Pakistan has approved the emergency use of COVID-19 vaccines made by China's CanSino and Sinopharm.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3